Search

everythinglearnresearchcommunity

for

Search:↓

Blocking COX, especially COX-2, in the skin can reduce inflammation and pain and may help prevent skin cancer.

Genotyping for NUDT15 p.Arg139Cys can help predict thiopurine side effects in Japanese IBD patients.

3D bioprinting is useful for making tissues, testing drugs, and delivering drugs, but needs better materials, resolution, and scalability.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Stopping isoniazid can reverse hair loss caused by the drug.

Guilu Erxian Glue may help reduce chemotherapy side effects like weight loss and heart stress.

Researchers identified five new potential targets for leishmaniasis treatment, suggesting repurposing existing drugs could be effective.

Some medications, including retinoids, antifungals, and psychotropic drugs, can cause reversible hair loss if stopped or doses are reduced.

Chemotherapy with docetaxel can cause painful nail and skin side effects that may lead to stopping treatment.

Topical Vorinostat shows promise for treating alopecia areata by promoting hair regrowth.

Dutasteride and finasteride affect different cell types differently.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Black seed oil significantly protects against hair loss from chemotherapy.

Enzymes are classified into six types and are essential for many biological processes, with only a few targeted by drugs.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Blocking the Wnt pathway could lead to new treatments for cancer and tissue repair but requires careful development to avoid side effects.

No treatment fully prevents hair loss from chemotherapy yet.

The document concludes that diagnosing and treating Human African Trypanosomiasis is challenging, but new treatments like fexinidazole are promising.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

Some cancer treatments can cause permanent hair loss.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Psychotropic medications can cause skin problems, including serious conditions, and patients should be monitored closely.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

Isoniazid can rarely cause hair loss, which is reversible after stopping the drug.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.